Lipid changes in tri-o-cresylphosphate-induced neuropathy.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002645:Chickens; D002784:Cholesterol / Q000032:analysis; D002800:Cholinesterase Inhibitors / Q000032:analysis; D003408:Cresols / Q000378:metabolism; D005260:Female; D008055:Lipids / Q000032:analysis*; D008099:Liver / Q000378:metabolism; D009422:Nervous System Diseases / Q000139:chemically induced*; D009474:Neurons / Q000187:drug effects; D010710:Phosphates / Q000378:metabolism; D010740:Phospholipases / Q000378:metabolism; D010743:Phospholipids / Q000032:analysis; D010756:Phosphoric Acids; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D012584:Sciatic Nerve / Q000032:analysis / Q000378:metabolism; D013045:Species Specificity; D013116:Spinal Cord / Q000032:analysis; D014280:Triglycerides / Q000032:analysis; D014688:Venoms / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D003408:Cresols; D008055:Lipids; D010710:Phosphates; D010743:Phospholipids; D010756:Phosphoric Acids; D014280:Triglycerides; D014688:Venoms; D002784:Cholesterol; D011335:Proadifen; D010740:Phospholipases